DrugShortagePulse: Analgesia/Addiction
32 drugShortagePulse: Analgesia/Addiction are listed from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), dated 2026-07-23 to 2026-11-02; the most frequent is Hikma Pharmaceuticals USA, Inc. with 8. Data last updated 2026-11-04; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
Includes: Manufacturer, Drug, Stage, Availability, Updated, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
32 records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), dated 2026-07-23 to 2026-11-02. Most frequent: Hikma Pharmaceuticals USA, Inc. (8). Each record links to a full report and the official source.
Last updated 2026-11-04. Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).
Get new DrugShortagePulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- Hikma Pharmaceuticals USA, Inc. (8)
- Hospira, Inc., a Pfizer Company (7)
- Fresenius Kabi USA, LLC (5)
- Padagis US LLC (5)
- Baxter Healthcare (1)
How do I get new drugShortagePulse: Analgesia/Addiction by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top drugShortagePulse: Analgesia/Addiction right now?
| Record | Drug | Stage | Availability |
|---|---|---|---|
| Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine Injection | Shortage revised (availability or dates changed) | Unavailable |
| Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride Injection | Shortage revised (availability or dates changed) | Unavailable |
| Hospira, Inc., a Pfizer Company | Fentanyl Citrate Injection | Shortage revised (availability or dates changed) | Limited availability |
| Hospira, Inc., a Pfizer Company | Morphine Sulfate Injection | Shortage revised (availability or dates changed) | Limited availability |
| Hospira, Inc., a Pfizer Company | Sufentanil Citrate Injection | Shortage revised (availability or dates changed) | Limited availability |
| Hospira, Inc., a Pfizer Company | Cisatracurium Besylate Injection | Manufacturer discontinuation | |
| Baxter Healthcare | Ketorolac Tromethamine Injection | Shortage reverified (still listed) | Unavailable |
| Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride Injection | Shortage reverified (still listed) | Unavailable |
| Fresenius Kabi USA, LLC | Ketorolac Tromethamine Injection | Shortage reverified (still listed) | Unavailable |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate Injection | Shortage reverified (still listed) | Unavailable |
| Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate Injection | Shortage reverified (still listed) | Unavailable |
| Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine Injection | Shortage reverified (still listed) | Unavailable |
| Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride Injection | Shortage revised (availability or dates changed) | Available |
| Fresenius Kabi USA, LLC | Remifentanil Hydrochloride Injection | Shortage revised (availability or dates changed) | Available |
| Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride Injection | Shortage revised (availability or dates changed) | Available |
| Hikma Pharmaceuticals USA, Inc. | 🔒 Unlock all 32 records → | ||
| Hikma Pharmaceuticals USA, Inc. | 🔒 Unlock all 32 records → | ||
| Piramal Critical Care Inc. | 🔒 Unlock all 32 records → | ||
Browse 17 more matching record reports
- Hikma Pharmaceuticals USA, Inc.
- Hikma Pharmaceuticals USA, Inc.
- Piramal Critical Care Inc.
- Padagis US LLC
- Padagis US LLC
- Padagis US LLC
- Padagis US LLC
- Padagis US LLC
- Teva Pharmaceuticals USA, Inc.
- Gland Pharma Limited
- Hospira, Inc., a Pfizer Company
- Mylan Institutional, a Viatris Company
- Amphastar Pharmaceuticals, Inc.
- Fresenius Kabi USA, LLC
- Fresenius Kabi USA, LLC
- Hikma Pharmaceuticals USA, Inc.
- XGen Pharmaceuticals DJB, Inc.
Browse all DrugShortagePulse record reports
Which related categories and locations should I check?
Browse by stage
Shortage reverified (still listed) (173) Shortage revised (availability or dates changed) (84) Manufacturer discontinuation (78) Resolved (10) New shortage posted (8)
Browse by therapeutic category
Anesthesia (73) Cardiovascular (35) Endocrinology/Metabolism (33) Oncology (32) Psychiatry (32) Anti-Infective (30) Neurology (15) Other (12) Rheumatology (10) Gastroenterology (9) Hematology (9) Dermatology (8) Antiviral (7) Pulmonary/Allergy (5) Medical Imaging (4)
Frequently asked questions
How many drugShortagePulse: Analgesia/Addiction are listed?
32 records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), last refreshed automatically. The most recent is dated 2026-11-02.
Can I get alerts for Analgesia/Addiction?
Yes. DrugShortagePulse can email you new records matching this filter; plans are listed on the DrugShortagePulse page.
Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list). Informational only. RSS feed of new records